Bilcare Limited has submitted to the Exchange about the disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
BI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bilcare's Board, via a circular resolution on June 4, 2026, decided not to convert 3,15,000 warrants it held in Caprihans India Limited into equity shares. The warrants will lapse as the exercise window expired on the same day, and the upfront subscription amount of Rs. 1,57,50,000 (about Rs. 1.58 crore) paid by Bilcare will be forfeited. The Company cited its current liquidity position, capital allocation priorities, and overall business requirements as the reasons for the decision. This effectively ends Bilcare's potential equity exposure in Caprihans India Limited.
Shareholders should note a one-time write-off of approximately Rs. 1.58 crore on the forfeited subscription amount, though this is small relative to Bilcare's overall size. The decision signals that management is prioritising liquidity and internal capital needs over the optional investment in Caprihans, with no impact on Bilcare's core business operations.